| Year |
Citation |
Score |
| 2018 |
Engleman EA, Steagall KB, Bredhold KE, Breach M, Kline HL, Bell RL, Katner SN, Neal-Beliveau BS. Show Preference for Stimulants and Potential as a Model Organism for Medications Screening. Frontiers in Physiology. 9: 1200. PMID 30214414 DOI: 10.3389/Fphys.2018.01200 |
0.305 |
|
| 2016 |
Engleman EA, Katner SN, Neal-Beliveau BS. Caenorhabditis elegans as a Model to Study the Molecular and Genetic Mechanisms of Drug Addiction. Progress in Molecular Biology and Translational Science. 137: 229-52. PMID 26810004 DOI: 10.1016/Bs.Pmbts.2015.10.019 |
0.33 |
|
| 2006 |
Eiler WJ, Masters J, McKay PF, Hardy L, Goergen J, Mensah-Zoe B, Seyoum R, Cook J, Johnson N, Neal-Beliveau B, June HL. Amphetamine lowers brain stimulation reward (BSR) threshold in alcohol-preferring (P) and -nonpreferring (NP) rats: regulation by D-sub-1 and D-sub-2 receptors in the nucleus accumbens. Experimental and Clinical Psychopharmacology. 14: 361-76. PMID 16893279 DOI: 10.1037/1064-1297.14.3.361 |
0.458 |
|
| 2005 |
Xu ZC, Ling G, Sahr RN, Neal-Beliveau BS. Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion. Brain Research. 1038: 163-70. PMID 15757632 DOI: 10.1016/J.Brainres.2005.01.033 |
0.607 |
|
| 1999 |
Neal-Beliveau BS, Joyce JN. Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions Neurotoxicology and Teratology. 21: 129-140. PMID 10192273 DOI: 10.1016/S0892-0362(98)00044-0 |
0.759 |
|
| 1998 |
Thomas WS, Neal-Beliveau BS, Joyce JN. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum Developmental Brain Research. 111: 99-106. PMID 9804909 DOI: 10.1016/S0165-3806(98)00126-6 |
0.76 |
|
| 1998 |
Neal-Beliveau BS, Joyce JN. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development Developmental Psychobiology. 32: 313-326. PMID 9589220 DOI: 10.1002/(Sici)1098-2302(199805)32:4<313::Aid-Dev6>3.0.Co;2-Q |
0.764 |
|
| 1997 |
Frohna PA, Neal-Beliveau BS, Joyce JN. Delayed plasticity of the mesolimbic dopamine system following neonatal 6-OHDA lesions Synapse. 25: 293-305. PMID 9068128 DOI: 10.1002/(Sici)1098-2396(199703)25:3<293::Aid-Syn9>3.0.Co;2-6 |
0.683 |
|
| 1996 |
Joyce JN, Frohna PA, Neal-Beliveau BS. Functional and molecular differentiation of the dopamine system induced by neonatal denervation Neuroscience and Biobehavioral Reviews. 20: 453-486. PMID 8880735 DOI: 10.1016/0149-7634(95)00025-9 |
0.723 |
|
| 1995 |
Frohna PA, Neal-Beliveau BS, Joyce JN. Neonatal 6-hydroxydopamine lesions lead to opposing changes in the levels of dopamine receptors and their messenger RNAs Neuroscience. 68: 505-518. PMID 7477961 DOI: 10.1016/0306-4522(95)00155-C |
0.704 |
|
| 1993 |
Neal-Beliveau BS, Joyce JN, Lucki I. Serotonergic involvement in haloperidol-induced catalepsy. The Journal of Pharmacology and Experimental Therapeutics. 265: 207-17. PMID 8386235 |
0.611 |
|
| 1993 |
Neal-Beliveau BS, Joyce JN. D1 and D2 dopamine receptors do not up-regulate in response to neonatal intrastriatal 6-hydroxydopamine lesions Neuroscience Letters. 160: 77-80. PMID 8247338 DOI: 10.1016/0304-3940(93)90917-A |
0.769 |
|
| 1993 |
Frohna PA, Neal-Beliveau BS, Joyce JN. Neonatal 6-OHDA lesions upregulate adult expression of tyrosine hydroxylase mRNA Neuroreport. 4: 1095-1098. PMID 8106005 |
0.674 |
|
| Show low-probability matches. |